BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38641203)

  • 1. Uveal melanoma: Current evidence on prognosis, treatment and potential developments.
    Gelmi MC; Jager MJ
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100060. PubMed ID: 38641203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
    Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology and genetics of uveal melanoma.
    Griewank KG; Murali R
    Pathology; 2013 Jan; 45(1):18-27. PubMed ID: 23222249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease.
    Shildkrot Y; Wilson MW
    Curr Opin Ophthalmol; 2009 Nov; 20(6):504-10. PubMed ID: 19644367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DEVELOPMENT AND CHALLENGES IN TREATMENT OF UVEAL MELANOMA].
    Zloto O; Vishnevskia-Dai V; Moisseiev J; Fabian ID
    Harefuah; 2018 Feb; 157(2):95-98. PubMed ID: 29484864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in uveal melanoma.
    Singh AD; Shields CL; Shields JA
    Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New immunotherapy approaches as the most effective treatment for uveal melanoma.
    Eteghadi A; Ebrahimi M; Keshel SH
    Crit Rev Oncol Hematol; 2024 Feb; 194():104260. PubMed ID: 38199429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current molecular and clinical insights into uveal melanoma (Review).
    Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathological basis of the argument in the treatment of melanoma of the uveal tract].
    Li YP
    Zhonghua Yan Ke Za Zhi; 2012 Nov; 48(11):971-5. PubMed ID: 23302268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving systemic targeted therapy strategies in uveal melanoma and implications for ophthalmic management: a review.
    Goh AY; Layton CJ
    Clin Exp Ophthalmol; 2016 Aug; 44(6):509-19. PubMed ID: 26601795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior uveal melanoma. The Swedish perspective.
    Seregard S
    Acta Ophthalmol Scand; 1996 Aug; 74(4):315-29. PubMed ID: 8883543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and histopathological features of choroidal melanoma-related enucleated eyes in a Spanish tertiary hospital.
    García Tirado A; Asencio Durán M; Berjón A; Ruiz Bravo-Burguillos E; Peralta Calvo J
    Arch Soc Esp Oftalmol (Engl Ed); 2019 May; 94(5):225-231. PubMed ID: 30904338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uveal melanoma.
    Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
    Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
    Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
    Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.
    Khan SA; Almalki WH; Arora S; Kesharwani P
    Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic prognostication in uveal melanoma.
    Dogrusöz M; Jager MJ
    Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.